SGLT2 inhibitors: an evidence-based update on cardiovascular implications

I Forzano, S Wilson, A Lombardi… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known
as 'gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent …

SGLT2 inhibitors: an evidence-based update on cardiovascular implications

I Forzano, S Wilson, A Lombardi… - EXPERT OPINION ON …, 2023 - iris.unimol.it
Abstract IntroductionSodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known as'
gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent randomized …

SGLT2 inhibitors: an Evidence-Based Update on cardiovascular Implications

I Forzano, S Wilson, A Lombardi… - Expert opinion on … - pubmed.ncbi.nlm.nih.gov
Introduction Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known as' gliflozins')
represent a cornerstone to treat diabetes mellitus. Moreover, recent randomized clinical …

SGLT2 inhibitors: an evidence-based update on cardiovascular implications

I Forzano, S Wilson, A Lombardi… - Expert Opinion on …, 2023 - einstein.elsevierpure.com
Abstract Introduction: Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known as
'gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent randomized …

[PDF][PDF] SGLT2 inhibitors: an evidence-based update on cardiovascular implications

I Forzano, S Wilson, A Lombardi, SS Jankauskas… - 2023 - researchgate.net
ABSTRACT Introduction: Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known
as 'gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent …

[引用][C] SGLT2 inhibitors: an Evidence-Based Update on cardiovascular Implications.

I Forzano, S Wilson, A Lombardi… - Expert Opinion on …, 2023 - europepmc.org
Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known as' gliflozins') represent a
cornerstone to treat diabetes mellitus. Moreover, recent randomized clinical trials have …